Roche, Ab­b­Vie forced to slam brakes on myelo­ma stud­ies of star drug Ven­clex­ta af­ter re­searchers flag high­er risk of death

Two heavy­weight phar­ma play­ers to­day said they’ve been forced to stop re­cruit­ing pa­tients for all on­go­ing stud­ies in­volv­ing Ven­clex­ta (vene­to­clax) for mul­ti­ple myelo­ma. Roche and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER